KAI-7535
K7535-2101
Phase 2 small_molecule active
Quick answer
KAI-7535 for Obesity is a Phase 2 program (small_molecule) at Kailera Therapeutics with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Kailera Therapeutics
- Indication
- Obesity
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active